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Vitamin C is a critical dietary nutrient in human which has a wide range of regulatory
effects on gene expression and physiology of Mycobacterium tuberculosis that leads
to a dormant drug-tolerant phenotype. In the presence of iron, vitamin C shows a
high bactericidal activity even in the drug resistant phenotype of M. tuberculosis. The
regulatory mechanisms underlying vitamin C induced adaptations are largely unknown
due to lack of functional genomics data in this field. In this study, we attempt to
characterize the direct effect of vitamin C treatment on the physiology of actively growing
Mycobacterium smegmatis. The study chose M. smegmatis as it is a fast-growing
bacterium and a non-pathogenic model system which shares many physiological
features with the pathogenic M. tuberculosis including dormancy and its regulation.
The proteomic adaptation of M. smegmatis on vitamin C treatment demonstrates the
important changes in cellular and metabolic process such as reversal of tricarboxylic acid
cycle, decrease in ATP synthesis, decrease in iron acquisition and storage, and induction
of dormancy regulators WhiB3, PhoP, and Lsr2.
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Introduction
Tuberculosis (TB) which is only second to HIV/AIDS, is one of the deadliest infectious diseases
of our time, causing 1.3 million deaths in 2012 (WHO, 2014). The World Health Organization
(WHO) reports suggest that one third of the world’s population is infected with latent TB. The
etiologic agent, Mycobacterium tuberculosis, has the ability to survive in the latent stage for years
before reactivation and subsequent induction of full-fledged disease. The cornerstone of TB control
efforts has been compromised by the outbreak ofMDR (multi drug resistance) and XDR (extremely
drug resistance)M. tuberculosis. In 2012 WHO estimated about 450,000 people who developed the
multidrug-resistant TB (MDR-TB) and there were about 170,000 deaths from MDR-TB across the
globe. The first-line drugs isoniazide and rifampicin potentially kills 99.0–99.9% ofM. tuberculosis
cells in vitro within 4–7 days. However, resistance to these bactericidal drugs develops very fast
under both in vitro and in vivo conditions. Therefore, there is an urgent need to discover potential
anti-microbial compounds as well as develop new methods for the prevention and treatment of
disease, more importantly, new therapies that provide longer sustainability and effectiveness against
bacterial pathogens.
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In humans, vitamin C is an essential dietary micronutrient
with antioxidant property which is involved in a wide range of
vital cellular and physiological functions (Mandl et al., 2009).
Vitamin C not only affects a number of metabolic reactions
and biological processes but also have medical relevance in
curing various diseases. The vitamin C supplement in human
diet has led to the elimination of scurvy (Hodges et al., 1969)
and has proven to be beneficial in the treatment of viral and
bacterial infections (McCormick, 1951; Pauling, 1976; Padayatty
et al., 2003). In 1976, Linus Pauling advocated a high dosage
(1–3 g/day) of vitamin C for the prevention of common cold and
flu. Vitamin C also demonstrated bacteriostatic and bactericidal
effect in several pathogenic bacteria like Staphylococcus aureus,
Escherichia coli, and Streptococcus sp. A number of reports have
described an improved effect of orally administered vitamin C in
preventing and treating TB infection in human and guinea pig
(McConkey and Smith, 1933; Hemila et al., 1999), while other
studies have reported the deficiency of vitamin C in TB patients
(Andosca and Foley, 1948). The action of vitamin C in infectious
disease is generally attributed to the effects on host cell mediated
immunity, such as enhanced T- cell response and migration of
leukocytes to the site of infection (Field et al., 2002). Furthermore,
it protects host from oxidative and nitrostative damage occurring
due to generation of reactive oxygen species and reactive nitrogen
species to kill intracellular pathogen (Jariwalla and Harakech,
1996). Pichat and Reveilleau postulated that the bactericidal
activity of vitamin C could be due to vitamin C itself or its
decomposition product(s) (Pichat and Reveilleau, 1950, 1951).
As a defense mechanism the host immune cells have the ability
to concentrate ascorbic acid to millimolar levels intracellularly
(Bergsten et al., 1990; Washko et al., 1993; Welch et al., 1995;
Laggner et al., 1999).
In a recent report, vitamin C induced a dormancy phenotype,
which showed hallmark features like bacteriostasis and drug
tolerance, in aerobically growing M. tuberculosis (Taneja et al.,
2010). Similarly, another study demonstrated a correlation
between the high vitamin C content of some medicinal
plant extracts and their potent activity against M. tuberculosis
(Narwadiya et al., 2011). Furthermore, vitamin C enhances the
bactericidal activity against M. tuberculosis in the presence of
a transition metal like ferrous that leads to the generation of
reactive oxygen species by Fenton’s reaction and affects several
biological processes (Vilchèze et al., 2013). These studies suggest
that vitamin C directly affect pathogen physiology. Vitamin C
has both anti-oxidant and a pro-oxidant property and hence
the sterilizing effect of vitamin C on M. tuberculosis cultures
remained controversial (Taneja et al., 2010; Vilchèze et al., 2013).
An incomplete understanding of the physiology of bacteria
associated with vitamin C has been an impediment toward
the therapeutic advancement of vitamin C. In this report we
attempt to characterize the effect of vitamin C treatment on the
proteome profile ofMycobacterium smegmatis, a non-pathogenic
organism closely related to M. tuberculosis. M. smegmatis share
hallmark features of dormancy with M. tuberculosis, making
it a suitable model system for this study. The availability of
the complete genome sequences for Mycobacterium strains have
made bioinformatics, genomics, and proteomics studies more
precise to obtain a better understanding of the pathophysiology
of Mycobacterium sp. Currently, it is easier to highlight
pathways with higher sensitivity, to explore a rational drug-
discovery program (Smith et al., 1997; Cole et al., 1998; Garnier
et al., 2003). In comparison to mRNA studies, proteomic
analysis is more focused on functional products, consequently,
providing a more accurate assessment of the conditional changes.
Traditionally, two-dimensional gel electrophoresis coupled
with mass spectrometry (2D-PAGE-MS) is used for protein
identification and quantification to study conditional changes in
the sample. In contrast to its popularity, this method remains
ambiguous due to its low load ability which results in multiple
spots for a single protein or multiple proteins in a single spot.
Along with poor separation of hydrophobic, acidic or alkaline
proteins, quantitative analysis of proteins remained uncertain
due to undetermined post-translational modifications, protein
degradation, protein isoforms and variability in tryptic digest
recovery from the gel. To compensate for these limitations of 2D-
PAGE-MS, an advanced gel-free and label free method had been
developed (Silva et al., 2005). We used the same method with
some modifications for proteomic characterization of vitamin
C treated M. smegmatis cells using Liquid Chromatography-
elevated energy Mass spectrometry (LC/MSE).
Materials and Methods
Chemicals, Culture Maintenance, and Media
All the chemicals used in the study were purchased from Sigma-
Aldrich, USA, except Dubos medium which was purchased
from DIFCO, USA. The stock culture of M. smegmatis strain
ATCC 607 was maintained at −70◦C on Dubos-agar slants and
subcultured once in Dubosmedium before inoculation to defined
experimental media.
Dose Response of M. smegmatis in the Presence
of Ascorbic Acid
The inhibitory activity of vitamin C on growing M. smegmatis
was tested by following the method previously described (Khan
and Sarkar, 2006). Briefly, 1% mid-log phase of a culture at a
cell density of 1 O.D.620nm was inoculated in 20ml of defined
medium (0.5 g KH2PO4, 0.2 g sodium citrate, 60mgMgSO4, 0.5 g
asparagine and 2mL glycerol in 100mL of distilled water at pH
6.6) in a 100ml conical flask and was incubated for 3 days under
aerobic conditions at 37◦C with shaking at 150 rpm (Thermo
Electron Model No. 481; Thermo Electron Corp., Marietta, OH).
Vitamin C was added into the defined medium at the time of
inoculation at the final concentration ranging from 0.125 to
2.0mM, with negative control being an equal volume of only
defined medium. Growth of M. smegmatis was estimated after a
3 day incubation period by determining the colony forming units
(CFU/ml).
Preparation of Mycobacterium smegmatisWhole
Cell Proteome
For comparative quantitative analysis of proteins in active bacilli
and vitamin-induced bacilli, 0.1% mid-log phase of a culture at a
cell density of 1 O.D.620nm was inoculated into 200ml of defined
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medium in a 1000ml conical flask and was incubated under
aerobic conditions at 37◦Cwith shaking at 150 rpm. Once culture
reached 0.5 O.D.620nm, 2mM of Vitamin C at final concentration
was added in defined medium and for control an equal volume
of only defined medium was added and was incubated under
aerobic conditions at 37◦C with shaking at 150 rpm. After
6 h, 250ml 0.5 O.D600 of the bacterial cells were harvested by
centrifugation at 10,700 g for 30min. The pellet was resuspended
in extraction buffer (urea 8 M, thiourea 2 M, dithiothreitol
40mg/ml and 3-[(3-Cholamidopropyl)dimethylammonio]-
1-propanesulfonate (CHAPS) 2%). After resolubilization,
sonication was done at 75Hz with 30 s pulse with a break of
45 s. This cycle was repeated for eight times. Proteins were
precipitated by trichloroacetic acid and Acetone extraction in
the ratio of 1: 8 to the protein sample. This consortium was kept
at−20◦C for 2 h and then centrifugation was done at 16,800 g for
1 h. The precipitate was further solubilized in extraction buffer
and used for further studies. In each sample, concentrations of
proteins solubilized in extraction buffer were estimated using the
One Plus 2D quantitation kit (Amersham Biosciences, USA).
Trypsin Digestion of Mycobacterium smegmatis
Whole Proteome
Approximately, 10µg complex protein mixture was taken
and washed twice with 50µL of 0.1% Rapigest™ (Waters
Corporation, Milford, MA) (1 vial diluted in 1000µL 50mM
ammonium bicarbonate) using a MW 5000 (or MW 3000) cut
off spin column. Protein solution was concentrated to 10–20µL
using a MW 5000 (or MW 3000) cut-off spin column. The
concentrated protein solution was then heated to 80◦C for
15mins and then 3µL of 100mM dithiothreitol (prepared in
50mM ammonium bicarbonate) was added before heating at
60◦C for 15min. Then 3µL of 200mM Iodoacetamide (made
up in 50mM ammonium bicarbonate) was added and the
solution was left in the dark at room temperature for 30min.
1µL of 1µg/µl (2µL of 0.5µg/µl) trypsin (prepared in 50mM
ammonium bicarbonate) was added and the solution was left
overnight at 37◦C. 1µL of concentrated HCl was added and
the solution was incubated at 37◦C for 20min before mixing
and later centrifuged at 36,000 g for 30min. The supernatant
was transferred to a clean eppendorf tube and the digest was
transferred to nano LC/MSE analysis.
LC/MSE Analysis
For LC/ MSE an earlier method was used with modifications
(Silva et al., 2005). Briefly, each trypsin digested protein sample
was spiked with an internal standard (tryptic digest of alcohol
dehydrogenase from Sacchromyces cervesie) at a level of 50 fmol
per 10µL injection before LC/MSE analysis. For sample analysis,
10µL aliquots of proteome tryptic digests were analyzed in
triplicates by LC/MSE using a nano ACQUITY ultra pressure
liquid chromatograph and Premier Quadrupole-Time of Flight
(Q-ToF) mass spectrometer equipped with a nanolock spray ion
source (Waters Corporation, USA). Samples, at a flow rate of
10µL/min, were injected onto a C18 trapping cartridge (300µm
i.d. × 1 cm length, Waters Corporation, USA). Peptides were
further separated, at a flow rate of 300 nL/min using a linear
gradient from 2 to 40% B over 120mins (A = 0.1% formic acid
in water, B = 0.1% formic acid in acetonitrile), by using gradient
elution onto a 75µm i.d. × 25 cm column, 1.7µm particle size,
packed with BEH C18 Stationary phase (Waters Corporation,
USA). Precursor ions and associated fragments were acquired
by operating the Q-Tof in the LC/MSE mode of acquisition,
where alternating 2 s scans of low (4V) collision energies were
used to generate either intact peptide ions or high (10–32V)
collision energies were used to generate peptide product ions.
An external standard for mass calibration, Glu-fibrino peptide
at a concentration of 200 fmol/µL (m/z 785.8426) was injected
through the nanolock spray ion source at a constant flow rate of
600 nL/min andmonitored every 30 sec. Samples were injected as
sets based on the treatment from earliest to latest time points. The
sensitivity and performance of the instrument was monitored
by analyzing a protein standard (tryptic digest of bovine serum
albumin) prior to the first sample injection and again following
the last sample injection.
Data Processing and Database Searching
Protein Lynx Global Server V 2.2.5 software (PLGS 2.2.5)
(Waters Corporation, USA) was used to process acquired raw
data files to generate precursor mass lists as well as associated
product ion mass lists for subsequent protein identification
and quantification. After processing each data file was searched
against the Uniprot protein database (http://www.uniprot.org/)
using the IDENTITYE database search algorithm within PLGS
2.2.5. Before searching processed data files, the internal standard
alcohol dehydrogenase from Sacchromyces cerevisiae sequence
was added to the database to enable the absolute protein
quantification functionality in each sample. The precursor
intensity measurements acquired from the output file was
used to determine the relative quantification of protein. For
each protein, the redundant quantitative measurement obtained
from the multiple tryptic peptides were used to determine an
average relative fold change. For each average fold-change a 95%
confidence interval was determined from the standard deviation
of total number of tryptic peptides. For mass accuracy (10 ppm
for precursor ions and 15 ppm for product ions) a default search
parameters was used with an “automatic” setting at minimum for
1 peptide match per protein, 3 consecutive product ion matches
per protein, and 7 total product ion matches per protein. During
the database search a maximum of 1 missed tryptic cleavage site
was allowed.
Results
Effect of Vitamin C on growth of M. smegmatis
In this study, we used defined medium to emphasize the
comparable growth of the organism/s with respect to changes
in composition of media. Also, it avoids the interference
due to commonly used complex medium for Mycobacterium
sp. growth. Earlier it has been shown that under aerobic
condition and Wayne 0.5 headspace ratio model the growth
of M. smegmatis was comparable in both defined and other
complex media (Khan and Sarkar, 2006). Earlier reports suggest
that high concentrations of vitamin C inhibit the growth of
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various bacterial species, some of which include Helicobacter
pyroli, Staphylococcus aureus, and M. tuberculosis (Zhang et al.,
1997; Taneja et al., 2010; Narwadiya et al., 2011; Kallio et al.,
2012; Vilchèze et al., 2013). In order to validate same in M.
smegmatis, vitamin C was tested in aerobic condition at different
concentration. The effect on growth was observed by adding
vitamin C at different concentrations in the culture at the time
of inoculation and experiment was terminated at 3 days of
incubation (as described in “Materials and Methods”). It was
observed that cell number was reduced by 1.7 and 2.5 log when
vitamin C was used at 1.5 and 2.0mM concentration, respectively
(Figure 1). At 2mM concentration of vitamin C more than
90% of inoculated cells achieved bacteriostasis. Therefore, 2mM
concentration was used for the proteomic characterization study.
Global Expression Change in Vitamin C Treated
and Active Bacilli
Tryptic peptides generated for 2mM vitamin C treated and
control samples were analyzed by LC/MSE in triplicate. The
complete list of detected peptides was converted to a text
file containing all of the mass spectrometric and retention
time data using MASSLYNX and PLGS 2.2.5 software (Waters
Corporation, USA), for data quality assessment. Each detected
peptide component is annotated as an EMRT (exact-mass,
retention time pair). Quantitative analysis was performed using
the triplicate of same set of experiments. Figure 2A illustrates
the binary comparison of replicate injections for the average
intensity measurements between control and vitamin C treated
cells. The average standard deviation was ∼0.32 between the
relative intensity ratio of matched peptide components of the
control and 2mM vitamin C treated cells. The natural logarithm
of the ratio of the average intensities from both the condition,
vitamin C treated (denominator) vs. control (numerator), was
plotted against the average intensity of the total number of
matched peptide components between the vitamin C treated
FIGURE 1 | Effect of Vitamin C on the growth of bacilli. 0.1% of ∼1.0
OD620 M. smegmatis culture was inoculated in defined medium containing
different concentration of Vitamin C and was kept at 37◦C at 150 rpm under
identical conditions. After 3 days, CFU counts were taken as described in
“Materials and Methods.”
and control samples, Figure 2B. Similarly, the natural log of
the average intensities (all clusters) plotted against average
Mass, Figure 2C. The observed relative fold change from the
matched peptide components of the samples, control and vitamin
treated, were plotted to identify peptide components of interest
(Figure 2B). This method provides a useful filter which allows
one to perform a search with a decreased but robust subset
of peptide components. Total 463 peptide components were
identified which exhibited a log intensity fold change range from
0.19 to 6.4.
About 818 proteins with pI ranging from 3 to 11, were
identified using multiplex LC-MSE technique in M. smegmatis
grown in aerobic and vitamin C treated cultures. By using PLGS
V 2.2.5 analysis software result of three independent experiments
identified 185 proteins against M. smegmatis database with
significant folds of change in expression of proteins (The
complete list of these proteins is provided as complementary
data).
Energy and Fatty Acid Metabolism
Like other bacterial system, glucose in mycobacterium is largely
oxidized through glycolysis and to some extent through the
pentose phosphate pathway (PPP) (Jayanthi et al., 1975).
Glycolysis yields metabolites of central metabolism such as
pyruvate, phosphoenol pyruvate and acetyl-CoA, whereas, PPP
provides pentose sugar (ribose 5-P for nucleotide synthesis)
and reducing equivalents in form of NADPH for reductive
biosynthetic reactions. A derivative of fatty acids or sugars
catabolism, Acetyl CoA, is assimilated through the Krebs cycle or
tricarboxylic acid (TCA) cycle. TCA cycle provides biosynthetic
precursors and reducing equivalents for energy generation and
biosynthetic reactions. Enumeration of proteins encoding key
glycolytic, TCA cycle and PPP enzymes of M. tuberculosis were
down-regulated upon vitamin C treatment. However, succinate
dehydrogenase differs in response and was up-regulated in
vitamin C treated cells. This was in line with previous reports
where succinate dehydrogenase was up-regulated in response to
Wayne hypoxia and mouse in vivo model and this upregulation
was found to be associated with a remarkable accumulation
of succinate in the extracellular environment (Shi et al., 2010;
Watanabe et al., 2011). By analyzing radiolabeled isotopomers
of succinate authors concluded that this succinate is an outcome
of the TCA cycle switch toward the non-oxidative direction in
oxygen limiting condition (Watanabe et al., 2011).
Similarly, proteins encoding important genes of fatty acid
metabolism FadA and FadD and mycolic acid synthesis,
FabG, are down-regulated in vitamin C treated cells. However,
Cyclopropane fatty acyl phospholipid synthase was uniquely
expressed in vitamin C treated cells. Cyclopropanation ofmycolic
acids is uncommon in the cell wall of saprophytic species
such as M. smegmatis, however, this modification is associated
with pathogenic bacteria like M. tuberculosis, M. bovis, and
M. Chelonae (Minnikin et al., 1982). In addition, cyclopropane
ring modifications are found to have subtle effects on the
fluidity and permeability of the cell wall which compromises
the ability of bacteria to resist to oxidative stress (George et al.,
1995; Yuan et al., 1995). Similarly, in well studied E. coli and
Frontiers in Microbiology | www.frontiersin.org 4 May 2015 | Volume 6 | Article 451
Mishra and Sarkar Vitamin C induced changes in M. smegmatis
FIGURE 2 | Relative quantitative analysis of tryptic peptide identified
by LC/MSE. Each peptide component detected by LC/MSE is annotated as
an EMRT (exact-mass, retention time pair) (A) Binary comparisons of the log
intensity measurements obtained from the EMRTs for Vitamin C treatment vs.
Control (B) The natural log of the intensities (Vitamin C treated vs. control)
plotted against the natural log of the replicating ions detected in the control
sample. (C) The natural log of the average intensities (all clusters) plotted
against average Mass. For each protein, the redundant quantitative
measurement obtained from the multiple tryptic peptides were used to
determine an average relative fold change. For each average fold-change a
95% confidence interval was determined from the standard deviation of total
number of tryptic peptides.
other bacterial species that possess ability to cyclopropanate
their plasma membrane, this phenomenon occurs during the
transition from active growth to stationary phase, and as a
response to unfavorable environmental conditions such as low
pH, high temperatures and low oxygen availability (Wang and
Cronan, 1994; Grogan and Cronan, 1997).
ATP Related
ATP synthase, an essential enzyme in the energy metabolism,
is a validated drug target for the treatment of TB, and ATP
synthase inhibitors, such as diarylquinoline, is a promising drug
candidate which is potent against both active and dormant forms
of M. tuberculosis (Welch et al., 1995). ATP synthase is a multi-
subunit complex consists of a membrane-embedded F0 part and
a cytosolic F1 moiety (Welch et al., 1995). We found down-
regulation of major components of ATP synthase, ATP-αβγδε,
by 2.6–3 folds in comparison to vitamin C treatment (Table 2
and supporting online material). This enzyme is involved in ATP
synthesis by utilizing the proton-motive force (PMF) across the
bacterial cytoplasmic membrane. In several bacteria this reaction
can be reversed and ATP hydrolysis is utilized to maintain
PMF, this strategy assist bacteria to survive in the low oxygen
concentration environments (Andries et al., 2005). Previous
report suggests a strong down- regulation of ATP synthase is
characteristic of dormant bacilli in different models (Boyer,
2002).
Transcription and Translation Associated
The HspX protein is a dominant antigen produced by M.
tuberculosis during the latent stage of infection in different
animal model systems as well as in models that aim to mimic
granulomatous environment in vitro. Along with its association
with latency, it is also expressed during static growth, upon entry
into macrophages or under oxygen deprived condition (Yuan
et al., 1996, 1998). The earlier reports proposed the role of HspX
in enhancing the stability of proteins and cell structures, which
consequentially helps the bacilli maintain long-term survival
in adverse condition (Yuan et al., 1996; Cunningham and
Spreadbury, 1998). Interestingly, HspX induces both B-cell and
T-cell responses in patients with active TB as well as in healthy
people with latent infection (Davidow et al., 2005; Demissie et al.,
2006). In our study, HspX (MSMEG_3932) expressed exclusively
in vitamin C treated cells and remained undetected in control
samples.
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PhoP and Lsr2 are two important transcriptional regulators
that are uniquely expressed in vitamin C treated cells (Table 1).
Lsr2, is a M. tuberculosis analog of the H-NS nucleoid binding
protein (Colangeli et al., 2009; Gordon et al., 2010), whereas,
PhoP mediates a range of adaptation to enduring hypoxia
response, including upregulating DosR (Gonzalo-Asensio et al.,
2006, 2008; Ryndak et al., 2008). These claims are strengthened
by proposed regulatory network based on CHIP-sequencing as
PhoP binding to DosR is the strongest among 50 transcription
factors (Galagan et al., 2013). Furthermore, it also confirmed
direct binding between PhoP and the aprABC locus required
to mediate pH adaptation (Abramovitch et al., 2011; Galagan
et al., 2013). PhoP and Lsr2 bind upstream and directly regulate
WhiB, an essential gene (Gomez and Bishai, 2000), which is more
than 20-fold induced at late stationary phase, and more than
10-fold induced at low pH (Geiman et al., 2006). In addition
to unique expression of PhoP and Lsr2, WhiB a dormancy
regulator is up-regulated by more than 3-folds in vitamin C
treated mycobacterial cells (Table 1). The WhiB-like proteins
are unique to Actinomycetes, was first reported in Streptomyces
coelicolor and found to be essential for sporulation (Davis and
Chater, 1992; Soliveri et al., 2000). They are small proteins (75–
130 amino acids) with a conserved aspartate and a helix-turn-
helix-like motif and 4 conserved cysteine residues quintessential
for metal-coordinated DNA-binding proteins (Smith et al., 1997).
These 4 cysteines bind to a [4Fe-4S] cluster which changes
the conformation of the protein in a redox-dependent manner
(Jakimowicz et al., 2005; Singh et al., 2007). The M. tuberculosis
whiB genes are induced independently by various stimuli like
gradual oxygen depletion of the Wayne hypoxia model, and
in vivo mouse model, cyclic AMP and nitric oxide addition,
may add versatility to their suggested redox-sensing properties
(Larsson et al., 2012).
Bacterial chromosomes are primarily packaged into sub-
micrometer sized compact structures, termed as nucleoids.
The structure and dynamics of nucleoids is determined by
the combination of several factors like DNA supercoiling,
macromolecular crowding and architectural nucleoid-associated
proteins (NAP). The emerging model of suggest that NAP not
only associated with the structure of the chromosomes but
are also involved in process like replication, recombination,
repair and transcription (Dillon and Dorman, 2010). NAP
is identified as an essential gene for M. tuberculosis in
high-density mutagenesis and deep sequencing exploration
studies (Sassetti et al., 2003; Sassetti and Rubin, 2007; Griffin
et al., 2011). Furthermore, the small molecule inhibitors of
NAP- HU disrupted nucleoid architecture and reduced M.
tuberculosis growth (Bhowmick et al., 2014). We found that NAP
(MSMEG_6280) is up-regulated by 4-folds inM. smegmatis upon
vitamin C treatment. The strong up-regulation of NAP suggests
that it has an important role in transcription regulation during
adaptation to vitamin C treatment. Increase expression of NAP
may have pre-emptive role in silencing energy metabolism genes
and preserving nucleoid structure.
Prokaryotic ubiquitin like Protein, Pup, is down-regulated by
3-fold in vitamin C treated cells which is known to target proteins
for degradation by mycobacterium proteosome. Pupylation is
an interesting protein interaction phenomenon and only known
post-translational modification system in prokaryotes but the
understanding of this process and its implication is still at
infancy.
Cell Wall and Cell Division
An optimal level of M. smegmatis FtsZ was required to sustain
cell division and that the cell division initiation mechanism was
also similar in other mycobacterial species (Dziadek et al., 2003).
Ftsz is a structural homolog of tubulin function as cell division
initiator in a GTP- dependent process. Its controlled interaction
with other cell division proteins in spatial and temporal manner
is considered as key event to bacterial cell division (Dziadek et al.,
2003). It was found that expression of FtsZ was decreased by
2.6-fold upon vitamin C treatment (Table 2).
Similarly,Wag31, a homolog of cell shape/cell division protein
DivIVA, is downregulated by 3-folds in vitamin C treated cells. It
TABLE 1 | Summary of proteins up-regulated in Vitamin C treated cells.
Uniprot accession no. Protein description PLGS score Control: Vitamin C Log(e)Ratio*
A0QT07 Succinate dehydrogenase 1130.6 −1.14± 0.29
A0R5R5 Cyclopropane fatty acyl synthase 602.28 Unique**
A0QZ83 14 kDa antigen hspX 3274.64 Unique**
A0R4L1 PhoP 876.78 Unique**
A0R576 Lsr2 1230.32 Unique**
A0QWV9 WhiB 1367.16 −0.99± 0.22
A0R5R1 Nucleoid associated protein 26950.02 −1.35± 0.35
A0R4H0 29 kDa antigen 1500.41 Unique**
A0QW82 Uncharacterized protein 1571.4 Unique**
A0R2E3 Uncharacterized protein 7595.02 −1.12± 0.15
A0R1B5 Uncharacterized protein 3607.62 −1.05± 0.15
A0R2J4 Uncharacterized protein 2426.8 −0.96± 0.2
*The natural log of the average relative intensity measurement for associated peptide ions from control divided by the average relative intensity measurement for the same ions found in
the Vitamin C treatment.
**Unique indicates a protein not detected in control.
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TABLE 2 | Summary of proteins down-regulated in Vitamin C treated cells.
Uniprot accession no. Description PLGS score Control: Vitamin C Log(e)Ratio*
Q3L887 Acyl CoA dehydrogenase fadE5 985.75 Unique**
A0R4Z5 Acetyl CoA acetyltransferase fadA6 1177.01 0.97 ± 0.28
A0QXY1 Acyl CoA ligase FadD31 549.12 Unique**
A0QU54 Acyl CoA dehydrogenase 619.53 1.35 ± 0.18
A0R2P1 3 Hydroxyacyl CoA dehydrogenase 1710.87 0.95 ± 0.16
A0R618 Acyl CoA synthase fadD32 1844.41 1.02 ± 0.08
A0R4C3 Phosphate ABC transporter phosphate binding protein PstS 3202.45 1.80 ± 0.09
A0R202 ATP synthase alpha atpA 5736.65 0.97 ± 0.06
A0R200 ATP synthase beta atpD 7370.45 1.04 ± 0.06
A0QZ48 Prokaryotic ubiquitin like protein Pup 4303.41 1.10 ± 0.25
A0R006 Cell wall synthesis protein Wag31 5047.6 1.12 ± 0.08
A0R012 Cell division protein FtsZ 2390.89 0.97 ± 0.14
A0R647 Bacterioferritin BfrB 12902.35 1.02 ± 0.06
A0QVZ3 Iron dependent repressor IdeR 4646.21 0.89 ± 0.19
A0QVU2 35 kDa protein 2650.75 1.09 ± 0.13
A0R4D0 Uncharacterized protein 8652.92 1.10 ± 0.1
A0QSK7 Uncharacterized protein 808.68 1.16 ± 0.24
*The natural log of the average relative intensity measurement for associated peptide ions from control divided by the average relative intensity measurement for the same ions found in
the Vitamin C treatment.
**Unique indicates a protein not detected in Vitamin C treated cells.
is essential for mycobacterial viability as well as for septal and
polar peptidoglycan synthesis and localizes at poles and septa
(Kang et al., 2008). Recently, cell division dynamics visualized
by using a merodiploid reporter strain expressing a Wag31-
GFP (green-fluorescent protein) and time-lapse fluorescence
microscopy concluded, cytokinesis and localization of Wag31
to the septum occurs very close together in time (Santi et al.,
2013). Wag31 is phosphorylated by Pyruvate kinase, and the
phosphorylated form is competent for polymerization and
localization to sites of peptidoglycan synthesis (Kang et al.,
2005). In our study, along with Wag31, Pyruvate kinase is
down-regulated by more than 2.5-fold in vitamin C treated cells
(Supporting online Material). The down-regulation of FtsZ and
Wag31 also explain the morphological changes like reduction
in size observed in ascorbic acid treated M. smegmatis cells
(Narwadiya et al., 2011).
Iron Related Proteins
In an aerobic environment, the two redox forms of iron Fe+2
and Fe+3 create a dilemma for living organisms. Fe+2 activates
dioxygen, with the general production of intermediate reactive
species causing serious hazards through oxidative damage
processes. On the other hand, Fe+3 has a low solubility under
physiological conditions (∼10−18 M) requiring living systems to
adopt more efficient iron storage/transport/usage mechanisms.
Bacterioferritins are ferritins containing haem that performs
the role of storage and supply of iron. In our study, down-
regulation of bacterioferritin protein BfrB by more than 2.5-
fold was observed upon vitamin C treatment. This iron storage
protein in Mycobacterium sp. has been previously reported
to be up-regulated under iron excess condition (Rodriguez
et al., 2002) and INH treatment. The decrease in synthesis
over degradation ratio of Bfr in presence of vitamin C is as
expected, as vitamin C induces dormancy in mycobacterial
cells; it makes little sense for the cells to synthesize the iron
storage proteins. It can be hypothesized that in presence of
vitamin C, cells increase the degradation of bacterioferritin to
release stored iron for important functions for example for
enzymes involved in respiratory processes. On same line, IdeR
(Iron dependent regulator) is a dual functional regulator that
controls transcription of genes involved in iron acquisition,
iron storage and survival in macrophages (Gold et al., 2001).
In our study, IdeR proteins were down-regulated by 2.5-fold
in vitamin C treated cells. Recently, it has been reported that
vitamin C pleiotropically affects the biological function and
enhances bactericidal activity in the presence of high levels of
iron. It seems the degradation of Bfr is implicates the high
oxidative environment of the cell which is essential for growth
Mycobacterium sp (Narwadiya et al., 2011). As described earlier,
siderophore molecules are considered as good targets because
pathogen survival and virulence is directly related to iron
availability.
Conserved Hypothetical
More than 25% ofmycobacterial proteome account for conserved
hypothetical proteins. These proteins are conserved through
Mycobacterium sp. but there function is still unknown. Previous
studies demonstrates there significant differential expression in
different conditions suggest their role in cellular homeostasis
but further studies are required to define their role in
mycobacteria. In our study, several conserved hypothetical
proteins were differentially expressed; an attempt was made to
postulate a metabolic role for few of the conserved hypothetical
proteins identified based on primary sequence homology using
the latest NCBI and Uniprot databases. MSMEG_5830 and
MSMEG_2850 were expressed exclusively in vitamin C treated
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cells. MSMEG_5830, is a homolog of 29 kD antigenic protein, it is
also identified as bacteriocin protein in different Mycobacterium
sp. (like Mycobacterium neoaurum, Mycobacterium kansasii,
and Mycobacterium rhodesiae). MSMEG_2850 is hemerythrin
cation binding domain annotated to have cell entry related
family protein. MSMEG_2695, MSMEG_5790, MSMEG_1513
are hypothetical proteins which are strongly down regulated
in vitamin C treated cells (Table 2). MSMEG_2695 is a 39 kD
alanine rich protein which contained a phage shock protein
A (PspA) signature domain. Interestingly, PspA from E. coli
is thought to facilitate the maintenance of the proton motive
force and is expressed in response to a variety of environmental
stressors, including inhibitors of lipid biosynthesis. Its homolog
in M. tuberculosis, Rv2744c, was earlier reported to be down-
regulated to same extent upon INH treatment. MSMEG_5790
is a homolog of SseC protein known for virulence regulation in
Salmonella sp. (Klein and Jones, 2001).
Discussion
Previous reports described that vitamin C is an essential
micronutrient which regulates a variety of biological functions.
Moreover, it has a strong epidemiological significance in a
number of diseases including diseases caused by bacterial
pathogens. Mostly effect of vitamin C is ascribed to the host
response and very little is known about its direct effect on
bacterial physiology. In this study, we attempt to elaborate
physiological consequences of vitamin C treatment in M.
smegmatis by proteome profiling. The complexity of responses
seen by proteome profiling is not surprising as a great deal of
information is generated and the cells response is not obvious
in terms of specific targets. However, this study provides an
integrated view of the components of M. smegmatis in response
to vitamin C. Our dose response studies of vitamin C on
mycobacterium concluded that at 2mM concentration, bacteria
attain bacteriostasis. We used 2mM concentration of vitamin
C for further proteome profiling study. In a previous study,
2mM concentration of vitamin C induced dos-regulon in M.
tuberculosis, which corresponded to the attainment of threshold
dissolved oxygen level in 100mins. In our study, we found that a
major component of dos-regulon, hspX, which is also chaperon
protein induced in presence of 2mM concentration of vitamin C.
Furthermore, dormancy regulator Whib3 was also induced at the
same concentration of vitamin C. This may be in correlation with
induction Phop and Lsr2 which directly regulate expression of
Whib3. In our study, we used 2mM concentration of vitamin C
that was 352µg/ml in solution. Previously various cohort studies
debated high dosage of vitamin C from 500mg- 2 g/day which
was found highly effective against heart diseases and strokes.
The key aspects of our study highlights that the metabolic
adaptation of M. smegmatis upon the treatment of vitamin
C was similar to the dormancy metabolism characterized by
the previous studies. For example, (1) reversal of TCA cycle,
the down-regulation of proteins involved in TCA cycle along
with up-regulation of succinate dehydrogenase upon vitamin C
treatment as observed earlier in growth arrest implies that the
TCA cycle function differed in this condition compare to actively
growing cells. The reversal of TCA cycle is an unfavorable and
energy consuming process which requires reducing equivalents
such as NADH. Noteworthy, levels of NADH is increased in
mycobacterial cells during dormancy. Up-regulation of succinate
dehydrogenase suggests the irreversible synthesis of fumarate
from succinate to maintain redox homeostasis during reductive
stress. (2) The re-routing of energy metabolism consequentially
decrease the level of ATP in cells along with down-regulation of
ATP synthase which is involved in ATP synthesis. The down-
regulation of ATP synthesis could be ascribed as a requirement
to maintain proton motive force across the cell membrane.
This phenomenon is hallmark to the bacilli attaining dormancy.
(3) The decrease in iron acquisition and storage proteins is
imperative in vitamin C treated bacilli as high concentration
of iron in medium will favor pro-oxidant property of vitamin
C. At high ferrous concentration vitamin C catalyzes hydroxyl
radicals and increase oxidative environment. Overall, induction
of important regulators of dormancy and shift in metabolism
suggests the proteomic adaptation of bacteria toward the
attainment of dormancy phenotype. A limitation of this study
includes that it was largely based on abundance of the proteins in
particular condition. However, the critical aspect of this study is
in line with earlier reports from different groups (Shi et al., 2010;
Taneja et al., 2010; Watanabe et al., 2011; Galagan et al., 2013).
Moreover, our results are in concordance with mycobacterial
response to Wayne hypoxia model and in vivo mouse model
(Shi et al., 2010; Watanabe et al., 2011; Galagan et al., 2013).
Furthermore, it identifies compelling questions regarding redox
signaling in mycobacterium which needs critical investigation.
Previous studies provide a foundation to ongoing efforts to
include vitamin C to anti-tuberculosis regime (Minnikin et al.,
1982; Shi et al., 2010; Abramovitch et al., 2011; Vilchèze et al.,
2013). On the other hand, conflicting reports have suggested
either beneficial or no effect of vitamin C in the treatment of TB
(Stone, 1972). Whether vitamin C is a potent therapeutic or not,
is beyond the scope of our study. However, this report highlights
the direct effect of vitamin C on bacterial physiology that may
serve as a rationale for the further studies in this research area.
Additionally, the importance of this study repose in the fact that
vitamin C is among the rarest of essential micronutrient which
can affect bacterial physiology to this large extent.
Complementary Data
Complete list of differentially expressed proteins in control and
vitamin C treated cells.
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